Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice

Arthritis and Rheumatism

Volumn 48, Issue 2, 2003, Pages 486-494

  Matsumoto, Keiko ^a   Watanabe, Norihiko ^a   Akikusa, Bunshiro ^b   Kurasawa, Kazuhiro ^a   Matsumura, Ryutaro ^c   Saito, Yasushi ^a   Iwamoto, Itsuo ^a   Saito, Takashi ^a,d  

^a CHIBA UNIVERSITY   (Japan)

^b Matsudo City Hospital   (Japan)

^c TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d RIKEN   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; DNA ANTIBODY; DOUBLE STRANDED DNA; FC RECEPTOR; IMMUNOGLOBULIN G;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIGEN ANTIBODY COMPLEX; ARTERY DIAMETER; ARTHUS PHENOMENON; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BACKCROSSING; COMPLEMENT DEPOSITION; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNE COMPLEX DEPOSITION; KIDNEY; LIFESPAN; LUNG; MOUSE; NECROTIZING ARTERITIS; NONHUMAN; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEINURIA; SKIN; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS;

ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIGEN-ANTIBODY COMPLEX; ARTHUS REACTION; FEMALE; IMMUNOGLOBULIN G; KIDNEY; LUNG; LUPUS NEPHRITIS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MRL LPR; MICE, KNOCKOUT; RECEPTORS, IGG; SURVIVAL RATE; VASCULITIS;

EID: 0037331250     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10813     Document Type: Article

References (36)

1. Kotzin BL. Systemic lupus erythematosus. Cell 1996;85:303-6.
2. Andrews BS, Eisenberg RA, Theofilopoulos AN, Izui S, Wilson CB, McConahey PJ, et al. Spontaneous murine lupus-like syndromes: clinical and immunopathological manifestations in several strains. J Exp Med 1978;148:1198-215.
3. Rozzo SJ, Drake CG, Chiang BL, Gershwin ME, Kotzin BL, Evidence for polyclonal T cell activation in murine models of systemic lupus erythematosus. J Immunol 1994;153:1340-51.
4. Takai T, Li M, Sylvestre D, Clynes R, Ravetch JV. FcR γ chain deletion results in pleiotrophic effector cell defects. Cell 1994;76:519-29.
5. Clynes R, Ravetch JV. Cytotoxic antibodies trigger inflammation through Fc receptors. Immunity 1995;3:21-6.
6. Park SY, Ueda S, Ohno H, Hamano Y, Tanaka M, Shiratori T, et al. Resistance of Fc receptor-deficient mice to fatal glomerulonephritis. J Clin Invest 1998;102:1229-38.
7. Sylvestre DL, Ravetch JV. Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade. Science 1994;265:1095-8.
8. Hazenbos WL, Gessner JE, Hofhuis FM, Kuipers H, Meyer D, Heijnen IA, et al. Impaired IgG-dependent anaphylaxis anc Arthus reaction in FcγRIII (CD16) deficient mice. Immunity 1996;5:181-8.
9. Sylvestre DL, Ravetch JV. A dominant role for mast cell Fc receptors in the Arthus reaction. Immunity 1996;5:387-90.
10. Sylvestre D, Clynes R, Ma M, Warren H, Carroll MC, Ravetch JV. Immunoglobulin G-mediated inflammatory responses develop normally in complement-deficient mice. J Exp Med 1996;184:2385-92.
11. Frank MM. Complement in the pathophysiology of human disease. N Engl J Med 1987;316:1525-30.
12. Couser WG. Mediation of immune glomerular injury. J Am Soc Nephrol 1990;1:13-29.
13. Gerard C, Gerard NP. C5A anaphylatoxin and its seven transmembrane-segment receptor. Annu Rev Immunol 1994;12:775-808.
14. Clynes R, Dumitru C, Ravetch JV. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 1998;279:1052-4.
15. 1 mice after treatment with a blocking monoclonal antibody specific for complement component C5. Proc Natl Acad Sci U S A 1996;93:8563-8.
16. Watanabe N, Akikusa B, Park SY, Ohno H, Fossati L, Vecchiett G, et al. Mast cells induce autoantibody-mediated vasculitis syndrome through tumor necrosis factor production upon triggering Fcγ receptors. Blood 1999;94:3855-63.
17. Cohen PL, Eisenberg RA. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 1991;9:243-69.
18. Hahn BH. Animal models of systemic lupus erythematosus. In Wallace DJ, Hahn BH, Quismorio FP Jr, Klinenberg JR, editors. Dubois' lupus erythematosus. 5th ed. Baltimore: Williams & Wilkins; 1997. p. 339-80.
19. Deo YM, Graziano RF, Repp R, van de Winkel JG. Clinical significance of IgG Fc receptors and FcγR-directed immunotherapies. Immunol Today 1997;18:127-35.
20. Daeron M. Fc receptor biology. Annu Rev Immunol 1997;15:203-34.
21. Nakamura A, Yuasa T, Ujike A, Ono M, Nakiwa T, Ravetch JV, et al. Fcγ receptor IIB-deficient mice develop Goodpasture's syndrome upon immunization with type IV collagen: a novel murine model for autoimmune glomerular basement membrane disease. J Exp Med 2000;191:899-906.
22. Shlomchik MJ, Madaio MP, Ni D, Trounstein M, Huszar D. The role of B cells in lpr/lpr-induced autoimmunity. J Exp Med 1994;180:1295-306.
23. Fossati-Jimack L, loan-Facsinay A, Reininger L, Chicheportiche Y, Watanabe N, Saito T, et al. Markedly different pathogenicity of four immunoglobulin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fcγ receptor III. J Exp Med 2000;191:1293-302.
24. Abdelmoula M, Spertini F, Shibata T, Gyotoku Y, Luzuy S, Lambert PH, et al. IgG3 is the major source of cryoglobulins in mice. J Immunol 1989;143:526-32.
25. Fulpius T, Spertini F, Reininger L, Izui S. Immunoglobulin heavy chain constant region determines the pathogenicity and the antigen-binding activity of rheumatoid factor. Proc Natl Acad Sci U S A 1993;90:2345-9.
26. Berney T, Fulpius T, Shibata T, Reininger L, Van Snick J, Shan H, et al. Selective pathogenicity of murine rheumatoid factors of the cryoprecipitable IgG3 subclass. Int Immunol 1992;4:93-9.
27. Itoh J, Nose M, Takahashi S, Ono M, Terasaki S, Kondoh E, et al. Induction of different types of glomerulonephritis by monoclonal antibodies derived from an MRL/lpr lupus mouse. Am J Pathol 1993;143:1436-43.
28. Lemoine R, Berney T, Shibata T, Fulpius T, Gyotoku Y, Shimada H, et al. Induction of "wire-loop" lesions by murine monoclonal IgG3 cryoglobulins. Kidney Int 1992;41:65-72.
29. Berney T, Shibata T, Izui S. Murine cryoglobulinemia: pathogenic and protective IgG3 self-associating antibodies. J Immunol 1991;147:3331-5.
30. Chan OT, Hannum LG, Haberman AM, Madaio MP, Shlomchik MJ. A novel mouse with B cells but lacking serum antibody reveal an antibody-independent role for B cells in murine lupus. J Exp Med 1999;189:1639-48.
31. Reininger L, Berney T, Shibata T, Spertini F, Merino R, Izui S. Cryoglobulinemia induced by a murine IgG3 rheumatoid factor skin vasculitis and glomerulonephritis arise from distinct pathogenic mechanisms. Proc Natl Acad Sci U S A 1990;87:10038-42.
32. Marino M, Ruvo M, De Falco S, Fassina G. Prevention of systemic lupus erythematosus in MRL/Ipr mice by administration of an immunoglobulin-binding peptide. Nat Biotechnol 2000;18:735-9.
33. Boackle SA, Holers VM, Chen X, Szakonyi G, Karp DR, Wakeland EK, et al. Cr2, a candidate gene in the murine Slelc lupu susceptibility locus, encodes a dysfunctional protein. Immunity 2001;15:775-85.
34. Morel L, Blenman KR, Croker BP, Wakeland EK. The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes. Proc Natl Acad Sci U S A 2001;98:1787-92.
35. Hopken UE, Lu B, Gerard NP, Gerard C. Impaired inflammaton, responses in the reverse Arthus reaction through genetic deletior of the C5a receptor. J Exp Med 1997;186:749-56.
36. Shah SV. Role of reactive oxygen metabolites in experimenta glomerular disease. Kidnev Int 1989:35:1093-106.